These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 30615878)
21. A molecular structure matching approach to efficient identification of endogenous mammalian biochemical structures. Hamdalla MA; Ammar RA; Rajasekaran S BMC Bioinformatics; 2015; 16 Suppl 5(Suppl 5):S11. PubMed ID: 25859612 [TBL] [Abstract][Full Text] [Related]
22. In silico drug exploration and discovery using DrugBank. Wishart DS Curr Protoc Bioinformatics; 2007 Jun; Chapter 14():Unit 14.4. PubMed ID: 18428789 [TBL] [Abstract][Full Text] [Related]
23. Searching the Cambridge Structural Database for polymorphs. van de Streek J; Motherwell S Acta Crystallogr B; 2005 Oct; 61(Pt 5):504-10. PubMed ID: 16186651 [TBL] [Abstract][Full Text] [Related]
24. Accurate reproduction of 161 small-molecule complex crystal structures using the EUDOC program: expanding the use of EUDOC to supramolecular chemistry. Wang Q; Pang YP PLoS One; 2007 Jun; 2(6):e531. PubMed ID: 17565384 [TBL] [Abstract][Full Text] [Related]
25. Structural study of piracetam polymorphs and cocrystals: crystallography redetermination and quantum mechanics calculations. Tilborg A; Jacquemin D; Norberg B; Perpète E; Michaux C; Wouters J Acta Crystallogr B; 2011 Dec; 67(Pt 6):499-507. PubMed ID: 22101539 [TBL] [Abstract][Full Text] [Related]
26. Life-science applications of the Cambridge Structural Database. Taylor R Acta Crystallogr D Biol Crystallogr; 2002 Jun; 58(Pt 6 No 1):879-88. PubMed ID: 12037325 [TBL] [Abstract][Full Text] [Related]
27. Exploring the CSD Drug Subset: An Analysis of Lattice Energies and Constituent Intermolecular Interactions for the Crystal Structures of Pharmaceuticals. Ma CY; Moldovan AA; Maloney AGP; Roberts KJ J Pharm Sci; 2023 Feb; 112(2):435-445. PubMed ID: 36462705 [TBL] [Abstract][Full Text] [Related]
28. Hotspots API: A Python Package for the Detection of Small Molecule Binding Hotspots and Application to Structure-Based Drug Design. Curran PR; Radoux CJ; Smilova MD; Sykes RA; Higueruelo AP; Bradley AR; Marsden BD; Spring DR; Blundell TL; Leach AR; Pitt WR; Cole JC J Chem Inf Model; 2020 Apr; 60(4):1911-1916. PubMed ID: 32207937 [TBL] [Abstract][Full Text] [Related]
35. How to Prepare a Compound Collection Prior to Virtual Screening. Bologa CG; Ursu O; Oprea TI Methods Mol Biol; 2019; 1939():119-138. PubMed ID: 30848459 [TBL] [Abstract][Full Text] [Related]
36. The role of cocrystals in pharmaceutical science. Shan N; Zaworotko MJ Drug Discov Today; 2008 May; 13(9-10):440-6. PubMed ID: 18468562 [TBL] [Abstract][Full Text] [Related]
37. X-ray crystallography of chemical compounds. Deschamps JR Life Sci; 2010 Apr; 86(15-16):585-9. PubMed ID: 19303027 [TBL] [Abstract][Full Text] [Related]
38. Occurrence of pharmaceutically acceptable anions and cations in the Cambridge Structural Database. Haynes DA; Jones W; Samuel Motherwell WD J Pharm Sci; 2005 Oct; 94(10):2111-20. PubMed ID: 16136575 [TBL] [Abstract][Full Text] [Related]
40. Institutional profile: Crystal structure information in drug discovery and development: current perspectives and new possibilities from the Cambridge Crystallographic Data Centre. Groom CR; Allen FH Future Med Chem; 2010 Jun; 2(6):933-9. PubMed ID: 21426112 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]